Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EPRS is a Critical Regulator of Cell Proliferation and Estrogen Signaling in ER+ Breast Cancer
PubMed Full text in PMC Similar studies SRA Run Selector
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor positive breast cancer
PubMed Full text in PMC Similar studies Analyze with GEO2R
Genome wide analysis of PAX2 chromatin interaction in MCF-7 cell
Genome wide analysis of transcripts regulated by PAX2 and Tamoxifen in MCF-7 cells
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Under conditions of hormonal adjuvant treatment the estrogen receptor apoprotein supports breast cancer cell cycling through the retinoic acid receptor α1 apoprotein
Effect of estrogen receptor- or retinoic acid receptor-knockdown on estrogen-sensitive MCF7 breast cancer cells
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade
breast cancer / tamoxifen monotherapy (microdissected tumor biopsies)
Estrogen positive breast cancer recurrence during tamoxifen therapy: microdissected tumor
Genome-wide transcriptomic and translatomic profiling in halofuginone and vehicle treated mouse fibroblasts
Expression data from paired matched breast cancer Fine needle aspiration (FNA) or Core needle biopsies (CBX)
ChIP-seq of MDA-MB-134 cell line
Endocrine response in invasive lobular carcinoma is characterized by unique estrogen-mediated gene expression and de novo tamoxifen resistance
Endocrine response in invasive lobular carcinoma is characterized by unique estrogen-mediated gene expression and de novo tamoxifen resistance (SUM44)
Endocrine response in invasive lobular carcinoma is characterized by unique estrogen-mediated gene expression and de novo tamoxifen resistance (MM134)
The transcription factor FOXM1 coordinates the expression of cell cycle-related genes and plays a pivotal role in tumorigenesis and cancer progression
Expression data from MCF7 and BT474 cell lines after long term estrogen deprivation culture
Estrogen- and Myc-regulated genes in MCF-7 breast cancer cells
ER ChIP-seq of Androstenedione treated Letrozole Resistant Breast Cancer Cell line
PubMed Similar studies SRA Run Selector
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on